BioSpace News Archive

The U.S. Healthcare Finance Solutions market size was valued at US$ 46.9 billion in 2021 and is expected to hit US$ 90.2 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.7% from 2022 to 2030.

According to Nova one advisor, The U.S. Stethoscope market size was valued at US$ 145.32 million in 2021 and is expected to hit US$ 221.06 million by 2030, growing at a compound annual growth rate (CAGR) of 8.7% from 2022 to 2030.

The global healthcare smart contracts market was surpassed at USD 1.7 billion in 2021 and is expected to hit around USD 7.9 billion by 2030, growing at a CAGR of 18.61 % from 2022 to 2030.

According to Report, the global bioelectric medicine market was estimated at USD 20.2 billion in 2021 and it is expected to surpass around USD 33.98 billion by 2030, poised to grow at a CAGR of 5.95 % from 2022 to 2030.

The global formulation development outsourcing market size was estimated at around USD 31.1 billion in 2021 and it is projected to hit around USD 61.6 billion by 2030, growing at a CAGR of 7.89% from 2022 to 2030.

Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced a publication on preclinical data supporting CPI-613® (devimistat) targeting carcinoma catabolism.

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced the appointment of Stephen Gould, Ph.D., as Chief Scientific Officer.

Alpha Tau Medical Ltd. announced that the Israeli Ministry of Environmental Protection has granted the Company an active radioactive license for use and possession of Thorium-228 and Radium-224, radioactive materials which are utilized in the production of the Alpha DaRT sources, in the main manufacturing floor of the Company’s production facility in Jerusalem.

Myovant Sciences announced that it approved equity awards for 23 new employees with a grant date of June 15, 2022 pursuant to Myovant’s 2020 Inducement Plan.

Novanta Inc. announced that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the CJS Securities 22nd Annual “New Ideas” Summer Conference on Tuesday, July 12, 2022, which is being held in Greenwich, CT.